Patients expected Profemur artificial hips to last. Then they snapped in half.

Bradley Little, a physical education teacher in Arizona, was leading his class through a school hallway in 2017 when he collapsed. Little feared he was having a stroke. Or, in a sign of the times, that he’d been shot. He tried to stand, but his leg wouldn’t move.

Johnson & Johnson files sNDA for SPRAVATO to treat depression

Treatment-resistant depression is characterised by an insufficient response to two or more oral antidepressants. Credit: DimaBerlin / Shutterstock. Johnson & Johnson is seeking approval for

July 23, 2024

Novel Oral Agent May Dial Down Ulcerative Colitis Severity

ORLANDO — For patients diagnosed with moderate to severe ulcerative colitis, the investigational agent icanbelimod had mixed results in reducing the severity of disease within

December 19, 2023

Medicare threatens to pull funding from HCA’s embattled Mission Hospital

Five years after investor-owned HCA Healthcare took over an esteemed nonprofit hospital in North Carolina, Medicare is threatening to cut off payment for any services

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.